Nicolas Epaillard

429 total citations
22 papers, 226 citations indexed

About

Nicolas Epaillard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Nicolas Epaillard has authored 22 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Nicolas Epaillard's work include Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (6 papers) and Cancer Genomics and Diagnostics (4 papers). Nicolas Epaillard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (6 papers) and Cancer Genomics and Diagnostics (4 papers). Nicolas Epaillard collaborates with scholars based in France, Spain and Argentina. Nicolas Epaillard's co-authors include Stéphane Oudard, Yann Vano, Marco Moreira, Audrey Simonaggio, Barbara Pistilli, Cheng‐Ming Sun, Réza Elaidi, Constance Thibault, Anne Vincent‐Salomon and Marc‐Henri Stern and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Nicolas Epaillard

17 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Epaillard France 9 149 106 64 59 28 22 226
Christopher Rossmann Austria 9 77 0.5× 158 1.5× 45 0.7× 51 0.9× 29 1.0× 11 220
Bibhusal Thapa Australia 11 179 1.2× 113 1.1× 37 0.6× 39 0.7× 19 0.7× 28 289
Vidhya Karivedu United States 10 129 0.9× 129 1.2× 71 1.1× 24 0.4× 40 1.4× 35 322
Priyanthi Kumarasinghe Australia 7 68 0.5× 94 0.9× 48 0.8× 25 0.4× 36 1.3× 18 230
Javier Valdivia Spain 8 70 0.5× 152 1.4× 91 1.4× 55 0.9× 36 1.3× 26 321
Manik Uppal United States 5 147 1.0× 188 1.8× 47 0.7× 28 0.5× 31 1.1× 11 304
Emeline Vinatier France 7 70 0.5× 155 1.5× 51 0.8× 21 0.4× 11 0.4× 14 268
Claudia Manini Italy 7 92 0.6× 76 0.7× 56 0.9× 35 0.6× 41 1.5× 32 206
Zhenzhen Hui China 10 91 0.6× 208 2.0× 49 0.8× 19 0.3× 11 0.4× 21 290
Katherine Vroobel United Kingdom 10 66 0.4× 68 0.6× 60 0.9× 16 0.3× 28 1.0× 29 225

Countries citing papers authored by Nicolas Epaillard

Since Specialization
Citations

This map shows the geographic impact of Nicolas Epaillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Epaillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Epaillard more than expected).

Fields of papers citing papers by Nicolas Epaillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Epaillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Epaillard. The network helps show where Nicolas Epaillard may publish in the future.

Co-authorship network of co-authors of Nicolas Epaillard

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Epaillard. A scholar is included among the top collaborators of Nicolas Epaillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Epaillard. Nicolas Epaillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benhamouda, Nadine, Alain Gey, Andrés J. Muñoz Martín, et al.. (2025). Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 44(1). 54–54. 2 indexed citations
2.
Epaillard, Nicolas, Amélie Lusque, William Jacot, et al.. (2024). Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort. ESMO Open. 9(5). 103447–103447. 3 indexed citations
3.
Oubaya, Nadia, Slim Fourati, Sébastien Beaune, et al.. (2023). Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clinical Microbiology and Infection. 29(7). 943.e1–943.e8. 24 indexed citations
4.
Epaillard, Nicolas, et al.. (2023). Current indications and future perspectives for antibody-drug conjugates in brain metastases of breast cancer. Cancer Treatment Reviews. 119. 102597–102597. 17 indexed citations
5.
Grinda, Thomas, et al.. (2023). Intracranial hypotension in a breast cancer patient treated with epidural blood patches. CNS Oncology. 12(1). CNS94–CNS94.
6.
Seguí, Elia, Édouard Auclin, David Casadevall, et al.. (2022). The FLARE score, circulating neutrophils, and association with COVID-19 outcomes in patients with solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 2551–2551.
7.
Epaillard, Nicolas, José Carlos Benítez, Elizabeth Fabre, et al.. (2021). Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study. Lung Cancer. 155. 114–119. 12 indexed citations
8.
Honoré, Charles, Arthur Géraud, Nicolas Epaillard, et al.. (2021). RCP Pacifique : bilan après un an et 323 cancers rares et/ou complexes discutés. Bulletin du Cancer. 108(12). 1077–1084.
9.
10.
Epaillard, Nicolas, Yohann Loriot, Pernelle Lavaud, et al.. (2021). Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. Frontiers in Oncology. 11. 9 indexed citations
11.
Jeannot, Emmanuelle, Lauren Darrigues, Marc Michel, et al.. (2020). A single droplet digital PCR for ESR1 activating mutations detection in plasma. Oncogene. 39(14). 2987–2995. 42 indexed citations
12.
Auclin, Édouard, N. Saoudi Gonzalez, Nicolas Epaillard, et al.. (2020). 1713P Active smoking and severity of COVID-19 infection in cancer patients. Annals of Oncology. 31. S1007–S1008. 1 indexed citations
13.
Epaillard, Nicolas, Audrey Simonaggio, Réza Elaidi, et al.. (2020). BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer. Bulletin du Cancer. 107(5). eS22–eS27. 35 indexed citations
14.
Seguí, Elia, Édouard Auclin, David Casadevall, et al.. (2020). 1714P Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score. Annals of Oncology. 31. S1008–S1008. 1 indexed citations
15.
Epaillard, Nicolas, José Carlos Benítez, Élizabeth Fabre-Guillevin, et al.. (2020). 42P Pleural effusion is a negative prognostic factor for immunotherapy in non small cell lung cancer (NSCLC): The PLUIE study. Annals of Oncology. 31. S1433–S1433. 2 indexed citations
16.
Seguí, Elia, Marta García de Herreros, Édouard Auclin, et al.. (2020). 1681P First results of the COCO study: COVID-19 outcomes in patients with cancer. Annals of Oncology. 31. S996–S996.
17.
Auclin, Édouard, Nicolas Epaillard, Marco Tagliamento, et al.. (2020). 1726P Expanding the role of medical oncologist in the management of COVID-19. Annals of Oncology. 31. S1012–S1012. 2 indexed citations
18.
Simonaggio, Audrey, Nicolas Epaillard, Réza Elaidi, et al.. (2020). Impact des signatures moléculaires sur le choix du traitement systémique du cancer du rein métastatique. Bulletin du Cancer. 107(5). S24–S34. 4 indexed citations
19.
Moreira, Marco, et al.. (2020). https://cdrjournal.com/article/view/3531. Cancer Drug Resistance. 3(3). 454–471. 14 indexed citations
20.
Bouaoud, Jebrane, Guillaume Beinse, Nicolas Epaillard, et al.. (2019). Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers. Oral Oncology. 95. 79–86. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Rossmann Breakdown of academic impact, for papers by Bibhusal Thapa Breakdown of academic impact, for papers by Vidhya Karivedu Breakdown of academic impact, for papers by Priyanthi Kumarasinghe Breakdown of academic impact, for papers by Javier Valdivia Breakdown of academic impact, for papers by Manik Uppal Breakdown of academic impact, for papers by Emeline Vinatier Breakdown of academic impact, for papers by Claudia Manini Breakdown of academic impact, for papers by Zhenzhen Hui Breakdown of academic impact, for papers by Katherine Vroobel
Rankless by CCL
2026